Browse Category

Mergers & Acquisitions 18 November 2025 - 21 November 2025

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri Corporation has kicked off one of the most consequential restructurings in its 170‑year history, agreeing to sell its Clean Earth hazardous‑waste business to France’s Veolia Environnement for $3.04 billion in cash and unveiling plans to spin off its remaining Harsco Environmental and Rail units into a new standalone public company dubbed “New Enviri.” Enviri+1
Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories (ABT) to Buy Exact Sciences in Up to $23 Billion Cancer Diagnostics Deal – All the Key News on November 20, 2025

Abbott Laboratories shook the healthcare and medtech markets today, November 20, 2025, by announcing a definitive agreement to acquire cancer diagnostics specialist Exact Sciences Corporation in an all‑cash transaction valuing the target at about $21 billion in equity and roughly $23 billion including debt. Reuters+2PR Newswire+2
PANW Stock Today (Nov 19, 2025): Palo Alto Networks beats Q1, announces $3.35B Chronosphere deal; shares swing after hours

PANW Stock Today (Nov 19, 2025): Palo Alto Networks beats Q1, announces $3.35B Chronosphere deal; shares swing after hours

November 19, 2025 — Palo Alto Networks packed multiple headlines into one day: fiscal Q1 2026 results that grew double‑digits, a definitive agreement to buy observability platform Chronosphere for $3.35 billion, a board refresh, and a new quantum‑safe collaboration with IBM. PR Newswire+4PR Newswire+4Reuters+4
Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

Palo Alto Networks to Acquire Chronosphere for $3.35B, Bringing AI‑Scale Observability to Cortex AgentiX

SANTA CLARA, Calif. — Palo Alto Networks announced today that it has entered into a definitive agreement to acquire Chronosphere, a fast‑growing cloud‑native observability platform, in a deal valued at $3.35 billion to be paid in cash and replacement equity awards. The companies said the transaction is expected to close in the second half of Palo Alto Networks’ fiscal 2026, pending customary regulatory approvals. PR Newswire+1
Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings (ONDS) Stock in Focus After Sentrycs Acquisition, Airport Defense Deal and Record Q3 2025 Earnings – November 19, 2025

Ondas Holdings Inc. remains one of the most talked‑about small‑cap defense and drone stocks this month. After a blistering rally driven by record third‑quarter results and a flurry of acquisitions, the stock is consolidating on Wednesday, November 19, 2025, as fresh research notes highlight both its explosive growth and its continuing risks.
Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding (NASDAQ: CHR) Stock Today: Tiny AI Metaverse Player Weighs Two Takeover Bids as Shares Spike Pre‑Market

Cheer Holding, Inc. is back on traders’ radar today after a fresh wave of headlines around a potential buyout and another burst of pre‑market volatility in its penny‑stock shares. The Beijing‑based mobile internet and AI company has formed a special committee to evaluate two competing cash offers for all of its Class A shares, while the stock continues to trade below 5 cents. Stock Titan+2Investing.com+2
KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

KVUE Stock Today (Nov. 18, 2025): Shares Slip as Appeals Court Weighs Tylenol Cases; Dividend Cleared; Kimberly‑Clark Deal Spread Persists

KVUE softened today after Monday’s developments in federal litigation tied to claims that prenatal acetaminophen use raises autism risk. A three‑judge appeals panel questioned the lower court’s dismissal of those cases, opening the door to their potential return and keeping headline risk front‑and‑center for the stock. Reuters
1 11 12 13 14 15 20
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.